We found an enrichment of anti-PAD2 antibodies in people with relapsing subtypes of MS (RRMS and SPMS), and a modest inverse correlation of anti-PAD2 antibody levels with disease severity. The gene discussed is PADI2; the disease is myeloid sarcoma.